Antitumor Effects of Selenium

• Published in: International journal of molecular sciences Vol. 22; no. 21; p. 11844
• Main Authors: Kim, Seung Jo, Choi, Min Chul, Park, Jong Min, Chung, An Sik
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 31.10.2021; MDPI
• Subjects: Adenosine; Antineoplastic Agents - therapeutic use; Antioxidants; Antitumor activity; Apoptosis; Cancer; Cancer therapies; Cell cycle; Cell growth; Chemotherapy; Clinical trials; Cytotoxicity; DNA damage; DNA methylation; Drug dosages; Drug resistance; Glutathione - analogs & derivatives; Glutathione - metabolism; Half-life; Humans; Kinases; Metabolism; Metabolites; Metastases; Metastasis; Methanol - analogs & derivatives; Methanol - metabolism; Methionine; Neoplasms - drug therapy; Neoplasms - metabolism; Neoplasms - pathology; Organoselenium Compounds - metabolism; Oxidation; Patients; Radiation; Radiation therapy; Review; ROS; Selenites; Selenium; selenium compounds; Selenium Compounds - metabolism; Sodium; Sodium Selenite - metabolism; Sodium Selenite - therapeutic use; Sulfhydryl groups; Toxicity; treatment of advanced cancer patients; Tumors; apoptosis; metastasis; selenium compounds; treatment of advanced cancer patients; ROS
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms222111844

Functions of selenium are diverse as antioxidant, anti-inflammation, increased immunity, reduced cancer incidence, blocking tumor invasion and metastasis, and further clinical application as treatment with radiation and chemotherapy. These functions of selenium are mostly related to oxidation and reduction mechanisms of selenium metabolites. Hydrogen selenide from selenite, and methylselenol (MSeH) from Se-methylselenocyteine (MSeC) and methylseleninicacid (MSeA) are the most reactive metabolites produced reactive oxygen species (ROS); furthermore, these metabolites may involve in oxidizing sulfhydryl groups, including glutathione. Selenite also reacted with glutathione and produces hydrogen selenide via selenodiglutathione (SeDG), which induces cytotoxicity as cell apoptosis, ROS production, DNA damage, and adenosine-methionine methylation in the cellular nucleus. However, a more pronounced effect was shown in the subsequent treatment of sodium selenite with chemotherapy and radiation therapy. High doses of sodium selenite were effective to increase radiation therapy and chemotherapy, and further to reduce radiation side effects and drug resistance. In our study, advanced cancer patients can tolerate until 5000 μg of sodium selenite in combination with radiation and chemotherapy since the half-life of sodium selenite may be relatively short, and, further, selenium may accumulates more in cancer cells than that of normal cells, which may be toxic to the cancer cells. Further clinical studies of high amount sodium selenite are required to treat advanced cancer patients.